Cath lab radiation dose reduaction, doseaware, raysafe
Feature | Cardiac Imaging | Dave Fornell

Each year radiology vendors use the Radiological Society of North America (RSNA) meeting as a springboard to unveil ...

Home January 12, 2016
Home
Technology | Balloon Catheter

NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the next-generation reusable cryoplasty inflation device.

Home January 12, 2016
Home
News | Wearables

Consumers from California, Colorado and Wisconsin filed a nationwide class action lawsuit against Fitbit Inc. alleging the company’s wrist-based “Charge HR” and “Surge” heart rate monitors do not and cannot consistently record accurate heart rates during the intense physical activity for which Fitbit expressly markets the devices.

Home January 12, 2016
Home
News | Cardiovascular Business

GE Healthcare announced that it has chosen Chicago as its global headquarters, effective early 2016.

Home January 12, 2016
Home
Technology | Cardiovascular Ultrasound

Fujifilm VisualSonics Inc. announced CE mark for the Vevo MD, what the company calls the world’s first ultra-high frequency (UHF) clinical ultrasound system. The announcement marks Fujifilm VisualSonics’ expansion into the clinical market.

Home January 11, 2016
Home
News | Cath Lab

A new study published online in JACC: Cardiovascular Interventions reveals that delays in recognizing symptoms of heart attack patients and seeking treatment are associated with increased damage to the heart.

Home January 08, 2016
Home
News | Stents Drug Eluting

In December, Stentys announced completion of patient enrollment in DESSOLVE III. The 1,400-patient randomized clinical trial will compare the MiStent SES sirolimus eluting absorbable polymer coronary stent system to Abbott’s Xience stent.

Home January 08, 2016
Home
News | Ventricular Assist Devices (VAD)

XENiOS announced that its i-COR Synchronized Cardiac Assist system protects left ventricular (LV) function compared to continuous-flow ECLS (extracorporeal life support) in cardiogenic shock.

Home January 08, 2016
Home
News | Stem Cell Therapies

January 7, 2016 — Celyad announced Dec. 21 that the U.S. Food and Drug Administration (FDA) has authorized the company’s ...

Home January 07, 2016
Home
Technology | Catheters

Roxwood Medical Inc. reported that more than 500 patients have been successfully treated as part of the initial limited release of its MicroCross Catheter, the latest addition to Roxwood Medical’s expanding product line. The MicroCross Catheter is U.S. Food and Drug Administration (FDA)-cleared and offered in two sizes (Micro14 and Micro18) for use in the coronary and peripheral vasculatures, providing enhanced guidewire support through challenging and tortuous anatomy.

Home January 07, 2016
Home
News | Cardiovascular Ultrasound

Stroke is the third leading cause of death in the Western industrialized world, and according to the Centers for Disease Control (CDC), accounts for one of every 19 deaths in the United States each year. Over 80 percent of strokes are ischemic in nature, caused by clots and other obstructions in vessels that supply blood to the brain, and cardiac embolism accounts for approximately one-third of all cases of ischemic stroke. Echocardiography in general and transesophageal echocardiography in particular are essential for evaluation, diagnosis and management of stroke and systemic embolism. A new document, Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism, will appear in the January 2016 issue of the Journal of the American Society of Echocardiography (JASE) and provides the first set of guidelines from the American Society of Echocardiography (ASE) specific to this topic.

Home January 07, 2016
Home
News | Heart Failure

January 7, 2016 — Scientists have found that women who suffer unexplained heart failure towards the end of pregnancy or ...

Home January 07, 2016
Home
News | Robotic Systems

Corindus Vascular Robotics Inc. announced the launch of a CorPath robotic-assisted coronary intervention program at Massachusetts General Hospital (MGH) and the installation of its first CorPath System.

Home January 06, 2016
Home
Feature | Clinical Decision Support | Dave Fornell

Clinical decision support (CDS) software has been discussed for years as a way to help clinicians follow best practice ...

Home January 06, 2016
Home
News | Left Atrial Appendage (LAA) Occluders

A new study determined that the Watchman left atrial appendage closure device is more cost-effective than warfarin and non-warfarin oral anticoagulants (NOACs) for stroke reductions in non-valvular atrial fibrillation patients.

Home January 06, 2016
Home
Subscribe Now